Edition:
United States

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.10USD
16 Feb 2018
Change (% chg)

$-0.05 (-2.33%)
Prev Close
$2.15
Open
$2.15
Day's High
$2.15
Day's Low
$2.10
Volume
404
Avg. Vol
10,541
52-wk High
$2.85
52-wk Low
$1.15

Chart for

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: 1.79
Market Cap(Mil.): $37.00
Shares Outstanding(Mil.): 17.62
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-Proteon Therapeutics Q3 ‍loss per share $1.08​

* Proteon Therapeutics announces third quarter 2017 financial results

Nov 07 2017

Earnings vs. Estimates